ASCO Virtual Meeting, 29 May–2 June 2020

Safety of BI 754111, an anti-LAG-3 mAb, in combination with BI 754091, an anti-PD-1 mAb, in patients with advanced solid tumors

Melissa Johnson, Manish R. Patel, Mohamad Cherry, Yoon-Koo Kang, Kensei Yamaguchi, Do-Youn Oh, Maen Hussein, Shigehisa Kitano, Shunsuke Kondo, Aaron Hansen, Ivor Percent, Ben George, Edward Arrowsmith, Manabu Morimoto, Christine Duffy, Miaomiao Ge, Maren Rohrbacher, Mabrouk Elgadi, Johanna Bendell

asco_2020_poster_127_johnson_lag3_pd1_1381.x_safety.png

  • 1381.2

1381.2.png

  • 1381.2 – Study design

1381.2_-_study_design.png

  • 1381.3

1381.3.png

  • 1381.4

1381.4.png

  • 1381.4 – Study design

1381.4_-_study_design.png

  • 1381.9

1381.9.png

  • 1381.9 – Study design

1381.9_-_study_design.png

  • References

references.png

Related Materials

Learn more about the science behind this poster in the videos, papers and other materials below.

FOR HEALTHCARE PROFESSIONAL ONLY

links_to_3rd_party.jpg